Altimmune Inc (NASDAQ: ALT) is -12.36% lower on its value in year-to-date trading and has touched a low of $2.09 and a high of $14.84 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ALT stock was last observed hovering at around $10.02 in the last trading session, with the day’s loss setting it -0.16%.
Currently trading at $9.86, the stock is -6.44% and -4.91% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 14.94 million and changing -1.65% at the moment leaves the stock 85.33% off its SMA200. ALT registered -9.79% loss for a year compared to 6-month gain of 253.40%. The firm has a 50-day simple moving average (SMA 50) of $1.40k and a 200-day simple moving average (SMA200) of -$4.96.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 9.43% loss in the last 1 month and extending the period to 3 months gives it a 51.23%, and is -5.10% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.62% over the week and 10.61% over the month.
Altimmune Inc (ALT) has around 52 employees, a market worth around $529.78M and $0.28M in sales. Profit margin for the company is -28124.01%. Distance from 52-week low is 371.77% and -33.56% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.07%).
Altimmune Inc quarterly earnings per share for the current quarter are estimated at -$0.43.The EPS is expected to grow by 18.02% this year.
Altimmune Inc (ALT) Top Institutional Holders
188 institutions hold shares in Altimmune Inc (ALT), with institutional investors hold 68.96% of the company’s shares. The shares outstanding are 53.73M, and float is at 53.18M with Short Float at 20.33%. Institutions hold 68.26% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 3.66 million shares valued at $12.93 million. The investor’s holdings represent 6.95% of the ALT Shares outstanding. As of Jun 29, 2023, the second largest holder is Nuveen Asset Management, LLC with 3.46 million shares valued at $12.21 million to account for 6.57% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 3.31 million shares representing 6.27% and valued at over $11.67 million, while Tang Capital Management, LLC holds 5.22% of the shares totaling 2.75 million with a market value of $9.71 million.
Altimmune Inc (ALT) Insider Activity
The most recent transaction is an insider purchase by Drutz David,the company’sDirector. SEC filings show that Drutz David bought 300 shares of the company’s common stock on Aug 15 ’23 at a price of $2.88 per share for a total of $862.0. Following the purchase, the insider now owns 29785.0 shares.
Altimmune Inc disclosed in a document filed with the SEC on Mar 24 ’23 that Eisenstadt Richard I (Chief Financial Officer) bought a total of 10,000 shares of the company’s common stock. The trade occurred on Mar 24 ’23 and was made at $4.31 per share for $43140.0. Following the transaction, the insider now directly holds 22010.0 shares of the ALT stock.
Still, SEC filings show that on Mar 23 ’23, Harris Matthew Scott (Chief Medical Officer) acquired 10,000 shares at an average price of $4.22 for $42200.0. The insider now directly holds 33,311 shares of Altimmune Inc (ALT).
